Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Chronic inflammatory bowel disease

Ustekinumab approved in Switzerland for ulcerative colitis

    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Market & Medicine
    • RX
  • 3 minute read

Swissmedic approves the use of the monoclonal antibody for the treatment of moderate to severe active ulcerative colitis where treatment goals are not achieved with conventional therapy.

Thus, for adult patients with ulcerative colitis who have had an inadequate response to conventional therapies or who have an intolerance or contraindication, there is another treatment option [1]. Ustekinumab is the first biologic available for this indication that selectively inhibits IL12 and IL23 signaling pathways, which play an important role in the pathomechanism of CU [2]. The Swissmedic approval is based on data from the pivotal Phase III UNIFI study program, which consisted of an induction study of at least eight weeks followed by a maintenance study of 44 weeks. Both demonstrated the efficacy of ustekinumab in patients with moderate-to-severe active CU for whom corticosteroids or immunomodulators or other biologics (TNF-alpha inhibitors and/or vedolizumab) have not been adequately responded to or tolerated [3,4]. Ustekinumab has demonstrated a consistent safety profile for the indication of CU, and the studies show that the treatment is generally well tolerated.

Milestone for patients with ulcerative colitis

CU is a severe, chronic, immune-mediated inflammatory disease of the colon. Across Europe, there are approximately 2.6 million affected individuals [5]. Unpleasant symptoms range from abdominal cramps and fatigue to bloody diarrhea and are painful as well as debilitating [6,7]. There may be a significant “burden of disease” associated with CU. For up to two-thirds of patients, current treatment options do not result in symptom relief or complications may occur [8–11]. “Today marks a significant milestone in the treatment of ulcerative colitis,” said Jan Wehkamp, MD, Gastroenterology Disease Area Leader at Janssen R & D. “Approximately 32,000 people in Switzerland suffer from one of two types of inflammatory bowel disease – Crohn’s disease and ulcerative colitis – and are in urgent need of effective treatment options [12]. Ustekinumab has been available to people with Crohn’s disease since its approval in 2017. Thanks to the patients who enrolled and were willing to participate in the UNIFI clinical trial program, it is now available to patients with ulcerative colitis and can give them a chance at lasting remission and relief from often painful and debilitating symptoms.”

Source: Janssen

 

Literature:

  1. STELARA® Technical Information (January 2020), www.swissmedicinfo.ch
  2. Toussirot E: The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases. Inflamm Allergy Drug Targets 2012; 11: 1159-1168.
  3. Sandborn WJ, et al: Abstract OP37: Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFI. ECCO 2019.
  4. Sands B, et al: Safety and efficacy of ustekinumab induction therapy in patients with moderate to severe ulcerative colitis: results from the phase 3 UNIFI study (abstract). Presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting, October 5-10, 2018; Philadelphia, Pennsylvania.
  5. Ng SC, et al: Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2017; 390: 2769-2778.
  6. Crohn’s & Colitis Foundation. “Living with Ulcerative Colitis” leaflet. Available at: www.crohncolitisfoundation.org
  7. Crohn’s & Colitis UK: What is Ulcerative Colitis? Available at: www.crohnsandcolitis.org.uk
  8. Lopez-Sanroman A, et al: Perceived emotional and psychological impact of ulcerative colitis on outpatients in Spain: UC-LIFE survey. Dig Dis Sci 2017; 62: 207-216.
  9. Rubin D, et al: The impact of ulcerative colitis on patients’ lives compared to other chronic diseases: a patient survey. Dig Sci 2010; 55: 1044-1052.
  10. Devlen J, et al: The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model. Inflamm Bowel Dis 2014; 20: 545-552.
  11. Lonnfors S, et al: IBD and health-related quality of life – Discovering the true impat. J Crohn’s Colitis 2014; 8: 1281-1286.
  12. Schöpfer A, Safroneeva E: Epidemiology and socio-economic aspects of inflammatory bowel disease in Switzerland 2018. https://ecocontent.hogrefe.com

 

GP PRACTICE 2020; 15(5): 29

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • COLITIS UCERosa
  • Crohn's disease
Previous Article
  • Acne vulgaris

Symptom-oriented treatment strategy

  • Dermatology and venereology
  • Education
  • RX
View Post
Next Article
  • Practice Strategies

Target group specific marketing concepts

  • Education
  • General Internal Medicine
  • Practice Management
  • Prevention and health care
  • RX
View Post
You May Also Like
View Post
  • 10 min
  • Cutaneous lupus erythematosus

From diagnostic workup to successful treatment

    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 4 min
  • Guideline update

Dietary recommendations for Crohn’s disease and colitis

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • Circadian rhythm during Ramadan

Disturbed sleep patterns lead to metabolic stress

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
View Post
  • 9 min
  • Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CA)

Diagnosis at an early stage, prognostic classifications and outlook

    • Cardiology
    • Education
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.